Cargando…

Impact of the progressive uptake of pneumococcal conjugate vaccines on the epidemiology and antimicrobial resistance of invasive pneumococcal disease in Gipuzkoa, northern Spain, 1998–2022

OBJECTIVES: To analyze the impact of pneumococcal conjugate vaccines (PCVs) on the incidence of invasive pneumococcal diseases (IPDs) and pneumococcal antibiotic resistance in Gipuzkoa, northern Spain for a 25 years period. METHODS: All cases of IPD confirmed by culture between 1998 and 2022 in a po...

Descripción completa

Detalles Bibliográficos
Autores principales:	Manzanal, Ayla, Vicente, Diego, Alonso, Marta, Azkue, Nekane, Ercibengoa, Maria, Marimón, José María
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Public Health
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10501722/ https://www.ncbi.nlm.nih.gov/pubmed/37719737 http://dx.doi.org/10.3389/fpubh.2023.1238502

Ejemplares similares

Dynamics of pneumococcal nasopharyngeal carriage in healthy children attending a day care center in northern Spain. influence of detection techniques on the results
por: Ercibengoa, María, et al.
Publicado: (2012)

Epidemiology and Clinical Features of Listeriosis in Gipuzkoa, Spain, 2010–2020
por: Vallejo, Pedro, et al.
Publicado: (2022)

Decrease of invasive pneumococcal disease (IPD) in adults after introduction of pneumococcal 13-valent conjugate vaccine in Spain
por: Càmara, Jordi, et al.
Publicado: (2017)

Progressive Decrease in the Potential Usefulness of Meningococcal Serogroup B Vaccine (4CMenB, Bexsero®) in Gipuzkoa, Northern Spain
por: Pérez-Trallero, Emilio, et al.
Publicado: (2014)

Prevalence of Chlamydia trachomatis infection in parturient women in Gipuzkoa, Northern Spain
por: Piñeiro, Luis, et al.
Publicado: (2016)

Hospitalizations for rotavirus gastroenteritis in Gipuzkoa (Basque country), Spain.
por: Cilla, G, et al.
Publicado: (1999)

Burden of Pneumococcal Disease in Northern Togo before the Introduction of Pneumococcal Conjugate Vaccine
por: Moïsi, Jennifer C., et al.
Publicado: (2017)

Pneumococcal Serotypes Associated with Community-Acquired Pneumonia Hospitalizations in Adults in Spain, 2016–2020: The CAPA Study
por: Menéndez, Rosario, et al.
Publicado: (2023)

Serotypes in Adult Pneumococcal Pneumonia in Spain in the Era of Conjugate Vaccines
por: Fernández-Delgado, Lucía, et al.
Publicado: (2021)

Uptake of pneumococcal vaccination in older people in northern Israel
por: Eilat-Tsanani, Sophia, et al.
Publicado: (2021)

A case of severe diarrhoea caused by Cyclospora cayetanensis in an immunocompromised patient in northern Spain
por: Alkorta, Miriam, et al.
Publicado: (2022)

Comparison of the Impact of Pneumococcal Conjugate Vaccine 10 or Pneumococcal Conjugate Vaccine 13 on Invasive Pneumococcal Disease in Equivalent Populations
por: Naucler, Pontus, et al.
Publicado: (2017)

Epidemiology of Invasive Pneumococcal Disease in Older People in Spain (2007–2009): Implications for Future Vaccination Strategies
por: Ardanuy, Carmen, et al.
Publicado: (2012)

Impact of Pneumococcal Conjugate Universal Routine Vaccination on Pneumococcal Disease in Italian Children
por: Fortunato, Francesca, et al.
Publicado: (2015)

Dynamic models of pneumococcal carriage and the impact of the Heptavalent Pneumococcal Conjugate Vaccine on invasive pneumococcal disease
por: Melegaro, Alessia, et al.
Publicado: (2010)

1722. Impact of Universal Conjugate Pneumococcal Vaccination in Infants on the Incidence and Mortality of Pneumococcal Meningitis in the General Population in Uruguay, South America (2005 – 2022).
por: Delfino, Marcos, et al.
Publicado: (2023)

Pneumococcal Immunization for Adults in 2022
por: O’Neill, John H.
Publicado: (2022)

Direct Effect of 10-Valent Conjugate Pneumococcal Vaccination on Pneumococcal Carriage in Children Brazil
por: Andrade, Ana Lucia, et al.
Publicado: (2014)

Strengths and weaknesses of pneumococcal conjugate vaccines
por: Micoli, Francesca, et al.
Publicado: (2023)

Autochthonous Nocardia cerradoensis Infection in Humans, Spain, 2011 and 2014
por: Ercibengoa, Maria, et al.
Publicado: (2016)

Invasive Pneumococcal Disease and 7-Valent Pneumococcal Conjugate Vaccine, the Netherlands
por: van Deursen, Anna M.M., et al.
Publicado: (2012)

Pneumococcal vaccination in persons living with HIV: Pneumococcal conjugate, polysaccharide or both?
por: Dhingra, Bhavna, et al.
Publicado: (2020)

Lung microbiome on admission in critically ill patients with acute bacterial and viral pneumonia
por: Marimón, Jose María, et al.
Publicado: (2023)

The Evolution and Distribution of Pneumococcal Serotypes in Adults Hospitalized With Community-Acquired Pneumonia in Spain Using a Serotype-Specific Urinary Antigen Detection Test: The CAPA Study, 2011–2018
por: Torres, Antoni, et al.
Publicado: (2021)

Effect of the different 13-valent pneumococcal conjugate vaccination uptakes on the invasive pneumococcal disease in children: Analysis of a hospital-based and population-based surveillance study in Madrid, Spain, 2007-2015
por: Picazo, Juan, et al.
Publicado: (2017)

Effectiveness of the 13-Valent Pneumococcal Conjugate Vaccine on Invasive Pneumococcal Disease in Greenland
por: Nikolova, Kristiana Alexandrova, et al.
Publicado: (2021)

The impact of introduction of the 10-valent pneumococcal conjugate vaccine on pneumococcal carriage in Nigeria
por: Adamu, Aishatu L., et al.
Publicado: (2023)

Dynamics of Streptococcus pneumoniae Serotypes Causing Acute Otitis Media Isolated from Children with Spontaneous Middle-Ear Drainage over a 12-Year Period (1999–2010) in a Region of Northern Spain
por: Alonso, Marta, et al.
Publicado: (2013)

Beyond new vaccine introduction: the uptake of pneumococcal conjugate vaccine in the African Region
por: Olayinka, Folake, et al.
Publicado: (2017)

Differences in Homing Potentials of Streptococcus pneumoniae–Specific Plasmablasts in Pneumococcal Pneumonia and After Pneumococcal Polysaccharide and Pneumococcal Conjugate Vaccinations
por: Palkola, Nina V., et al.
Publicado: (2015)

Clinical and microbiological implications of invasive pneumococcal disease in hospitalized patients (1998–2013)()
por: Medeiros, Marta Inês Cazentini, et al.
Publicado: (2016)

Systematic Review of the Indirect Effect of Pneumococcal Conjugate Vaccine Dosing Schedules on Pneumococcal Disease and Colonization
por: Loo, Jennifer D., et al.
Publicado: (2014)

1738. Cost-Effectiveness Analysis of Infant Pneumococcal Vaccination with the 20-Valent Pneumococcal Conjugate in the US
por: Rozenbaum, Mark, et al.
Publicado: (2023)

Accelerating Pneumococcal Conjugate Vaccine introductions in Indonesia: key learnings from 2017 to 2022
por: Athiyaman, Anithasree, et al.
Publicado: (2023)

1480. Incidence of Non-Invasive Pneumococcal Pneumonia in Children in the United States before and after Introduction Pneumococcal Conjugate Vaccines (PCV7 and PCV13) during 1998-2018
por: Hu, Tianyan, et al.
Publicado: (2020)

Genotypes, Recombinant Forms, and Variants of Norovirus GII.4 in Gipuzkoa (Basque Country, Spain), 2009–2012
por: Arana, Ainara, et al.
Publicado: (2014)

Pneumococcal Conjugate Vaccines and Otitis Media
por: Taylor, Sylvia, et al.
Publicado: (2012)

Effect of heptavalent pneumococcal conjugate vaccination on invasive pneumococcal disease in preterm born infants
por: Rückinger, Simon, et al.
Publicado: (2010)

Decrease in Pneumococcal Co-Colonization following Vaccination with the Seven-Valent Pneumococcal Conjugate Vaccine
por: Valente, Carina, et al.
Publicado: (2012)

Effect of Age and Vaccination With a Pneumococcal Conjugate Vaccine on the Density of Pneumococcal Nasopharyngeal Carriage
por: Roca, A., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_a0vqqu97i4m7msmkg7tubi4n5e